Resources
AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 39
PxPulse: The Advocacy Chronicles with APHA’s Yvette Raphael
Our debut episode of the Advocacy Chronicles features Yvette Raphael, the Executive Director of Advocacy for Prevention of HIV and AIDS (APHA) in South Africa, and a leader in the development of The Choice Manifesto.
Decolonizing Global Health: Dr. Madhukar Pai and COMPASS Africa Tell Us Why and How
In this episode of PxPulse, we talk about why and how the decisions that shape global health must be made by those facing the greatest risks. As the world evaluates the pandemic response and debates on decolonizing global health gain momentum, equity in global health has never been more urgent.
Inclusion of Pregnant and Lactating People in HIV Research
Produced and hosted by Jeanne Baron People who are pregnant or lactating (PLP) have historically been excluded from research because of concerns for the developing fetus. But this has led to a dearth of data on new interventions against health...
PEPFAR at 20: Keeping the promise
2023 is a big year for PEPFAR. Considered one of the greatest US foreign policy and global development achievements of the century, the program has saved upwards of 25 million lives since it launched in 2003. But PEPFAR is marking its 20th anniversary while fighting for its future.
Evolving Strategies for an HIV Vaccine: One researcher explains where the field is going and why?
Produced and hosted by Jeanne Baron With several large HIV vaccine trials in the last few years finding no efficacy, the field is in transition. There are diverse ideas in vaccine research, but there’s no clear concept that’s ready to...
Prevention Option:
PPPR Advocacy 101: Find out what it means to you
Over the coming months, global leaders will make key decisions about several initiatives to prepare for the next pandemic. What they commit to and how much they will spend, and how well these plans incorporate equity as a principle across all of these agreements, is in question.
The Shape of Pandemic Preparedness is Being Decided. Now is the Time for Collective Action.
Health leaders around the world are in the midst of creating a new architecture to deal with pandemics. In this episode of Px Pulse, Chris Collins, the CEO and President at Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, talks...
New Products Are Needed But a New Paradigm is Essential
This episode of PxPulse explores the shifting landscape in HIV prevention and how this moment gives the world a chance to finally reimagine how to DELIVER prevention.
Prevention Option:
Research Fundamentals: An HIV Vaccine — What’s the challenge and what’s the science?
Some vaccines are easier to develop than others. COVID-19 vaccines were developed with unprecedented speed, taking a matter of months to become available. A measles vaccine took about 10 years to develop. But the field’s been working on an HIV...
Prevention Option:
What Matters Right Now for Rolling Out the Ring and Injectable PrEP?
The HIV field has two new approved prevention options waiting in the wings, the dapivirine vaginal ring and injectable cabotegravir as PrEP. Until now, daily oral PrEP, first approved in 2012, has been the only drug-based strategy for HIV...
showing 1-10 of 39